The Mexican government is the only one who is providing the COVID-19 vaccine within the country, and private companies are not allowed to sell or distribute the vaccine. According to the World Health Organization, Mexico currently ranks 12th for COVID-19 infections, 4th for the number of COVID-19 deaths, and 1st for lethality. See this detailed report by Intertec, Asinta’s employee benefits consulting Partner in Mexico, for more information.
COVID-19 vaccine considerations for Mexico
- Can employers mandate the vaccine?
- Who will control delivery of the vaccine?
- Who covers the cost of the vaccine?
- Where will people get vaccinated?
Government designated vaccination locations
- Is there cultural resistance to getting the vaccine?
Unknown at this time
The Federal Commission for Protection Against Health Risks, COFEPRIS (its acronyms in Spanish), is a government entity regulating vaccines and medicines, a similar organization to the FDA in the U.S. The vaccines authorized to be used by COFEPRIS in Mexico are:
- AstraZeneca – Oxford University. (approved Dec. 4, 2020).
- CanSinoBIO (It is not yet authorized; however, the government has signed a pre-purchase contract of 35 million vaccines).
The government implemented a four-stage plan to vaccinate all the population:
- Stage 1: From December 2020 to February 2021 – Front-line health care personnel for control and care of COVID-19 patients.
- Stage 2: From February to April 2021 – Remaining health personnel and people over 60.
- Stage 3: From April to May 2021 – People from 50 to 59 years old.
- Stage 4: From May to June 2021 – People from 40 to 49 years old.
- Stage 5 From June 2021 to March 2022 – People from 40 to 49 years old.
More InformationIntertec Agente de Seguros y de Fianzas, Asinta's partner in Mexico.
Employee Benefits in Mexico
Get insights on mandatory and common supplementary employee benefits in Mexico.
Top 6 Vaccine Considerations
Use our decision matrix to help support your employees.
Page last modified: March 17, 2021
The information presented on this site is current as of the date initially posted; and, because matters related to COVID-19, the vaccine, and compliance measures are changing so quickly, it may not be current as of the date you read it. While the information gathered here is from Asinta global partners who are subject matter experts in their respective fields, this information is not meant to be a substitute for individual legal or medical advice, or as a substitute for advice in your specific situation.